Biotechnology venture capital firm Third Rock Ventures has raised $770m for its fifth fund, a sign that investor interest in funding early-stage science continues unabated despite volatile public markets.
The investment vehicle, the largest ever raised by Third Rock in its 12-year history, will support investments in 10 to 12 companies. The Boston-based firm’s new fund came together quickly.
The Georgia Tech alum is the first Spanish-born president of an American university.
The U.S. Small Business Administration (SBA) has announced the fifth round of its Growth Accelerator Fund Competition to recognize innovative accelerators, including incubators, co-working startup communities or other similar models, to compete for prizes of $50,000 each for a total of $3 million.
Emergent BioSolutions CEO Robert Kramer Sr. sits down with Yahoo Finance’s Dan Roberts, Melody Hahm and Myles Udland on “YFi AM” to discuss the fight over drug pricing and hear how the biopharmaceutical company is seeking to make Narcan, a life-saving drug that blocks the effects of an opioid overdose, more affordable and accessible.
Although the recent $110 million funding round for Thrive Earlier Detection Corp. was impressive — it is certainly not the biggest we’ve seen around Maryland to date.
The two health care organizations have been investing separately in health technology and companies for several years.
Altimmune, Inc. (ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its HepTcell and ALT-702 programs in the United States.
Johns Hopkins University is planning a bold new approach to career development for students and alumni that includes opening three new administrative offices, launching new initiatives, and better integrating career and life design into the academic and co-curricular experience of all Hopkins students and postdocs.
For augmenting readability, The Research Insights has added a fresh market study, titled Vaccines Market to its flared database. The report has been put together in a chapter-wise arrangement, by separating required illustrations transversely. This report is an expedient tool to get responses to some of the queries that hold significance for the growth of the Vaccines Market during the forecast period. The evidence in the report was congregated from qualified organizations & dependable sources and was further authenticated by industry specialists for increased integrity
The Biotechnology Innovation Organization (BIO) released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives” today at the 2019 BIO International Convention.
The fifth edition of the Best Practices Guide is the bioscience industry’s leading comprehensive analysis of state legislative and regulatory initiatives in support of economic development.
